PortfoliosLab logo
MOH vs. VRTX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between MOH and VRTX is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

MOH vs. VRTX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Molina Healthcare, Inc. (MOH) and Vertex Pharmaceuticals Incorporated (VRTX). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

MOH:

-0.01

VRTX:

-0.01

Sortino Ratio

MOH:

0.13

VRTX:

0.14

Omega Ratio

MOH:

1.02

VRTX:

1.02

Calmar Ratio

MOH:

-0.16

VRTX:

-0.05

Martin Ratio

MOH:

-0.47

VRTX:

-0.11

Ulcer Index

MOH:

12.39%

VRTX:

9.51%

Daily Std Dev

MOH:

45.23%

VRTX:

28.65%

Max Drawdown

MOH:

-68.37%

VRTX:

-91.77%

Current Drawdown

MOH:

-27.29%

VRTX:

-14.45%

Fundamentals

Market Cap

MOH:

$16.47B

VRTX:

$114.81B

EPS

MOH:

$20.88

VRTX:

-$3.84

PEG Ratio

MOH:

-0.62

VRTX:

2.66

PS Ratio

MOH:

0.41

VRTX:

10.34

PB Ratio

MOH:

3.79

VRTX:

6.96

Total Revenue (TTM)

MOH:

$41.85B

VRTX:

$11.10B

Gross Profit (TTM)

MOH:

$4.78B

VRTX:

$9.55B

EBITDA (TTM)

MOH:

$1.90B

VRTX:

-$76.30M

Returns By Period

In the year-to-date period, MOH achieves a 4.81% return, which is significantly lower than VRTX's 9.77% return. Over the past 10 years, MOH has outperformed VRTX with an annualized return of 15.80%, while VRTX has yielded a comparatively lower 13.48% annualized return.


MOH

YTD

4.81%

1M

-6.72%

6M

2.40%

1Y

-0.33%

3Y*

1.67%

5Y*

10.42%

10Y*

15.80%

VRTX

YTD

9.77%

1M

-13.24%

6M

-5.57%

1Y

-0.23%

3Y*

18.06%

5Y*

8.95%

10Y*

13.48%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Molina Healthcare, Inc.

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

MOH vs. VRTX — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MOH
The Risk-Adjusted Performance Rank of MOH is 4242
Overall Rank
The Sharpe Ratio Rank of MOH is 4949
Sharpe Ratio Rank
The Sortino Ratio Rank of MOH is 3939
Sortino Ratio Rank
The Omega Ratio Rank of MOH is 3939
Omega Ratio Rank
The Calmar Ratio Rank of MOH is 4141
Calmar Ratio Rank
The Martin Ratio Rank of MOH is 4040
Martin Ratio Rank

VRTX
The Risk-Adjusted Performance Rank of VRTX is 4545
Overall Rank
The Sharpe Ratio Rank of VRTX is 4949
Sharpe Ratio Rank
The Sortino Ratio Rank of VRTX is 4040
Sortino Ratio Rank
The Omega Ratio Rank of VRTX is 4040
Omega Ratio Rank
The Calmar Ratio Rank of VRTX is 4848
Calmar Ratio Rank
The Martin Ratio Rank of VRTX is 4848
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

MOH vs. VRTX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Molina Healthcare, Inc. (MOH) and Vertex Pharmaceuticals Incorporated (VRTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current MOH Sharpe Ratio is -0.01, which is comparable to the VRTX Sharpe Ratio of -0.01. The chart below compares the historical Sharpe Ratios of MOH and VRTX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

MOH vs. VRTX - Dividend Comparison

Neither MOH nor VRTX has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

MOH vs. VRTX - Drawdown Comparison

The maximum MOH drawdown since its inception was -68.37%, smaller than the maximum VRTX drawdown of -91.77%. Use the drawdown chart below to compare losses from any high point for MOH and VRTX.


Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

MOH vs. VRTX - Volatility Comparison

The current volatility for Molina Healthcare, Inc. (MOH) is 10.30%, while Vertex Pharmaceuticals Incorporated (VRTX) has a volatility of 13.31%. This indicates that MOH experiences smaller price fluctuations and is considered to be less risky than VRTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

MOH vs. VRTX - Financials Comparison

This section allows you to compare key financial metrics between Molina Healthcare, Inc. and Vertex Pharmaceuticals Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


2.00B4.00B6.00B8.00B10.00B12.00B20212022202320242025
11.15B
2.77B
(MOH) Total Revenue
(VRTX) Total Revenue
Values in USD except per share items

MOH vs. VRTX - Profitability Comparison

The chart below illustrates the profitability comparison between Molina Healthcare, Inc. and Vertex Pharmaceuticals Incorporated over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%40.0%60.0%80.0%20212022202320242025
11.5%
86.9%
(MOH) Gross Margin
(VRTX) Gross Margin
MOH - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Molina Healthcare, Inc. reported a gross profit of 1.28B and revenue of 11.15B. Therefore, the gross margin over that period was 11.5%.

VRTX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Vertex Pharmaceuticals Incorporated reported a gross profit of 2.41B and revenue of 2.77B. Therefore, the gross margin over that period was 86.9%.

MOH - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Molina Healthcare, Inc. reported an operating income of 433.00M and revenue of 11.15B, resulting in an operating margin of 3.9%.

VRTX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Vertex Pharmaceuticals Incorporated reported an operating income of 630.10M and revenue of 2.77B, resulting in an operating margin of 22.8%.

MOH - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Molina Healthcare, Inc. reported a net income of 298.00M and revenue of 11.15B, resulting in a net margin of 2.7%.

VRTX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Vertex Pharmaceuticals Incorporated reported a net income of 646.30M and revenue of 2.77B, resulting in a net margin of 23.3%.